Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Use of Guselkumab: Non-interventional Assessment of Real-world Outcomes

NCT07532213 is registered in ClinicalTrials.gov with Janssen-Cilag A.G., Switzerland as lead sponsor.

NCT NCT07532213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07532213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Use of Guselkumab: Non-interventional Assessment of Real-world Outcomes
Lead sponsor
Janssen-Cilag A.G., Switzerland
Phase
Observational
Overall status
Recruiting
Start date
April 13, 2026
Completion date
April 10, 2029
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colitis, ulcerative, crohn disease, inflammatory bowel disease